Novalis Biotech

Ottergemsesteenweg Zuid 808 Bus B511
9000 Gent
BE
Novalis Biotech
Foundation date
21/08/2017
Sector
#InvestorSubsector
Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.
Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.
Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.
As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more
-
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Read more